IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q3 2020 Holdings

Filed 2020-11-13 | 4 holdings | $459.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
10x Genomics, Inc.(TXG)CLASS A COMMON88025U109$436.8K3,503,52895.0%
Epizyme, Inc.(EPZMEUR)COM29428V104$10.3K862,4022.2%
Novavax, Inc.(NVAX)COM670002401$7.3K67,3731.6%
Acceleron Pharma Inc.(XLRN)COM00434H108$5.2K45,8841.1%